Daxor Gross Profit 2010-2011 | DXR

Daxor gross profit from 2010 to 2011. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Daxor Annual Gross Profit
(Millions of US $)
2011 $1
2010 $1
2009 $1
Daxor Quarterly Gross Profit
(Millions of US $)
2011-12-31 $0
2011-09-30 $0
2011-06-30 $0
2011-03-31 $0
2010-12-31 $0
2010-09-30 $0
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.037B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.868B 19.58
Encompass Health (EHC) United States $12.183B 25.83
DaVita (DVA) United States $10.978B 15.44
Chemed (CHE) United States $8.483B 26.66
Elanco Animal Health (ELAN) United States $6.417B 13.74
Option Care Health (OPCH) United States $5.441B 24.26
RadNet (RDNT) United States $4.587B 291.14
Amedisys (AMED) United States $3.105B 20.89
LifeStance Health (LFST) United States $2.271B 0.00
Addus HomeCare (ADUS) United States $2.054B 22.55
Astrana Health (ASTH) United States $1.524B 37.75
U.S Physical Therapy (USPH) United States $1.213B 31.31
Aveanna Healthcare Holdings (AVAH) United States $1.169B 66.56
Pennant (PNTG) United States $1.042B 38.25
Atai Life Sciences (ATAI) Germany $0.331B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00